Back to search
FDAFDA · Food and drugs·Recall number D-0332-2023

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0130-5

Published March 1, 2023 · Recall initiated: January 30, 2023

Summary

FDA records drug Class II recall D-0332-2023, published March 1, 2023 and initiated January 30, 2023. Recalling firm: IBSA PHARMA INC; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 220413, Exp. 10/2023; 220964, Exp. 3/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email if TIROSINT has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIROSINT
Manufacturer
IBSA PHARMA INC
Distributor
Nationwide in the USA.
UPC
0371858011754
Lot
Lot #: 220413, Exp. 10/2023; 220964, Exp. 3/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0130-5 recalled?

Yes. FDA published recall D-0332-2023 on March 1, 2023. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIROSINT. UPC: 0371858011754.